Philip Ron M bought AVTX
June 30, 2026 · Form 4 insider transaction
Philip Ron M bought 69 shares of Avalo Therapeutics, Inc. at $15.04 per share, a transaction worth $1.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
69
Price
$15.04
Total value
$1.0K
InsiderPhilip Ron M
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 30, 2026
Filing dateJuly 2, 2026
Shares owned after69
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The options were granted on June 30, 2026, and are 100% vested.